172
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Relationship of advanced oxidative protein products in human saliva and plasma: age- and gender-related changes and stability during storage

, , &
Pages 1201-1206 | Received 06 Apr 2012, Accepted 31 May 2012, Published online: 29 Jun 2012

References

  • Junqueira VB, Barros SB, Chan SS, Rodrigues L, Giavarotti L, Abud RL, Deucher GP. Aging and oxidative stress. Mol Aspects Med 2004;25:5–16 [PubMed: 15051312].
  • Zhang YB, Zhong ZM, Hou G, Jiang H, Chen JT. Involvement of oxidative stress in age-related bone loss. J Surg Res 2011;169:e37–2013;e42 [PubMed: 21529826].
  • Pandey KB, Mehdi MM, Maurya PK, Rizvi SI. Plasma protein oxidation and its correlation with antioxidant potential during human aging. Dis Markers 2010;29:31–36 [PubMed: 20826915].
  • Komosinska-Vassev K, Olczyk P, Winsz-Szczotka K, Kuznik-Trocha K, Klimek K, Olczyk K. Age- and gender-related alteration in plasma advanced oxidation protein products (AOPP) and glycosaminoglycan (GAG) concentrations in physiological ageing. Clin Chem Lab Med 2012;50:557–563 [PMID: 22505552].
  • Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49:1304–1313 [PubMed: 8731095].
  • Capeillère-Blandin C, Gausson V, Descamps-Latscha B, Witko-Sarsat V. Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochim Biophys Acta 2004;1689:91–102 [PubMed: 15196590].
  • Kalousová M, Zima T, Tesar V, Dusilová-Sulková S, Skrha J. Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. Mutation Res 2005;579:37–46 [PubMed: 16084533].
  • Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillère-Blandin C, Nguyen AT, Canteloup S, . Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 1998;161:2524–2532 [PubMed: 9725252].
  • Witko-Sarsat V, Nguyen-Khoa T, Jungers P, Drüeke TB, Descamps-Latscha B. Advanced oxidation protein products as a novel molecular basis of oxidative stress in uraemia. Nephrol Dial Transplant 1999;14:76–78 [PubMed: 10048460].
  • Matteucci E, Biasci E, Giampietro O. Advanced oxidation protein products in plasma: stability during storage and correlation with other clinical characteristics. Acta Diabetol 2001;38:187–189 [PubMed: 11855797].
  • Descamps-Latscha B, Witko-Sarsat V, Nguyen-Khoa T, Nguyen AT, Gausson V, Mothu N, . Early prediction of IgA nephropathy progression: proteinuria and AOPP are strong prognostic markers. Kidney Int 2004;66:1606–1612 [PubMed: 15458457].
  • Lazárová M, Stejskal D, Lacnák B, Václavík J, Adamovská S, Ochmanová R, Hanák V, Skácelová M. The antioxidant acetylcysteine reduces oxidative stress by decreasing level of AOPP. Biomed Papers 2004;148:131–133 [PubMed: 15744360].
  • Correa-Salde V, Albesa I. Reactive oxidant species and oxidation of protein and haemoglobin as biomarkers of susceptibility to stress caused by chloramphenicol. Biomed Pharmacother 2009;63:100–104 [PubMed: 18602793].
  • Chakraborty A, Chowdhury S, Bhattacharyya M. Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients. Diabetes Res Clin Pract 2011;93:56–62 [PubMed: 21146883].
  • Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956;11:298–300 [PubMed: 13332224].
  • Harman D. The biological clock: the mitochondria?J Am Geriartr Soc 1972;20:145–147 [PubMed: 5016631].
  • Harman D. Free radical theory of aging: an update: increasing the functional life span. Ann N Y Acad Sci 2006;1067:10–21 [PubMed: 16803965].
  • Hyun DH, Hernandez JO, Mattson MP, de Cabo R. The plasma membrane redox system in aging. Ageing Res Rev 2006;5:209–220 [PubMed: 16697277].
  • Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44–84 [PubMed: 16978905].
  • Pandey KB, Rizvi SI. Markers of oxidative stress in erythrocytes and plasma during aging in humans. Oxid Med Cell Longev 2010;3:2–12 [PubMed: 20716923].
  • Gil Del Valle L. Oxidative stress in aging: Theoretical outcomes and clinical evidences in humans. Biomedicine Aging Pathology 2011;1:1–7.
  • Yu BP, Chung HY. Adaptive mechanisms to oxidative stress during aging. Mech Ageing Dev 2006;127:436–443 [PubMed: 16497363].
  • Kaneda H, Taguchi J, Ogasawara K, Aizawa T, Ohno M. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis 2002;162:221–225 [PubMed: 11947918].
  • Zhou FL, Zhang WG, Wei YC, Meng S, Bai GG, Wang BY, . Involvement of oxidative stress in the relapse of acute myeloid leukemia. J Biol Chem 2010;285:15010–15015 [PubMed: 20233720].
  • Mezzano D, Pais EO, Aranda E, Panes O, Downey P, Ortiz M, . Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. Kidney Int 2001;60:1844–1850 [PubMed: 11703602].
  • Descamps-Latscha B, Witko-Sarsat V, Nguyen-Khoa T, Nguyen AT, Gausson V, Mothu N, London GM, Jungers P. Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients. Am J Kidney Dis 2005;45:39–47 [PubMed: 15696442].
  • Selmeci L, Székely M, Soós P, Seres L, Klinga N, Geiger A, Acsády G. Human blood plasma advanced oxidation protein products (AOPP) correlates with fibrinogen levels. Free Radic Res 2006;40:952–958 [PubMed: 17015275].
  • Selmeci L, Seres L, Soós P, Székely M, Acsády G. Kinetic assay for the determination of the oxidative stress biomarker, advanced oxidation protein products (AOPP) in the human blood plasma. Acta Physiol Hung 2008;95:209–218 [PubMed: 18642760].
  • Chen YH, Shi W, Liang XL, Liang YZ, Fu X. Effect of blood sample type on the measurement of advanced oxidation protein products as a biomarker of inflammation and oxidative stress in hemodialysis patients. Biomarkers 2011;16:129–135 [PubMed: 21133645].
  • Selmeci L. Advanced oxidation protein products (AOPP): novel uremic toxins, or components of the non-enzymatic antioxidant system of the plasma proteome?Free Radic Res 2011;45:1115–1123 [PubMed: 21740311].
  • Lentini P, de Cal M, Cruz D, Chronopoulos A, Soni S, Nalesso F, . The role of advanced oxidation protein products in intensive care unit patients with acute kidney injury. J Crit Care 2010;25:605–609 [PubMed: 20537505].
  • Barsotti A, Fabbi P, Fedele M, Garibaldi S, Balbi M, Bezante GP, . Role of advanced oxidation protein products and Thiol ratio in patients with acute coronary syndromes. Clin Biochem 2011;44:605–611 [PubMed: 21458436].
  • Fialová L, Malbohan I, Kalousová M, Soukupová J, Krofta L, Stípek S, Zima T. Oxidative stress and inflammation in pregnancy. Scand J Clin Lab Invest 2006;66:121–127 [PubMed: 16537245].
  • Codoñer-Franch P, Tavárez-Alonso S, Murria-Estal R, Tortajada-Girbés M, Simó-Jordá R, Alonso-Iglesias E. Elevated advanced oxidation protein products (AOPPs) indicate metabolic risk in severely obese children. Nutr Metab Cardiovasc Dis 2010;22:237–243 [PubMed: 20708392].
  • Martín-Gallán P, Carrascosa A, Gussinyé M, Domínguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med 2003;34:1563–1574 [PubMed: 12788476].
  • Pandey KB, Mishra N, Rizvi SI. Protein oxidation biomarkers in plasma of type 2 diabetic patients. Clin Biochem 2010;43:508–511 [PubMed: 19941844].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.